X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Merck Ltd with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs ACTAVIS (US) - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MERCK   ACTAVIS
EQUITY SHARE DATA
    MERCK
Dec-17
ACTAVIS
Dec-18
MERCK/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,35813,470-   
Low Rs9339,035-   
Sales per share (Unadj.) Rs665.03,304.1-  
Earnings per share (Unadj.) Rs56.6-1,064.2-  
Cash flow per share (Unadj.) Rs72.5348.2-  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.713,627.7-  
Shares outstanding (eoy) m16.60332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.4 50.6%   
Avg P/E ratio x20.2-10.6 -191.5%  
P/CF ratio (eoy) x15.832.3 48.9%  
Price / Book Value ratio x2.60.8 314.0%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,0113,742,567 0.5%   
No. of employees `0001.516.9 9.1%   
Total wages/salary Rs m1,6960-   
Avg. sales/employee Rs Th7,150.065,025.6 11.0%   
Avg. wages/employee Rs Th1,098.70-   
Avg. net profit/employee Rs Th608.2-20,944.8 -2.9%   
INCOME DATA
Net Sales Rs m11,0401,098,933 1.0%  
Other income Rs m24021,015 1.1%   
Total revenues Rs m11,2791,119,948 1.0%   
Gross profit Rs m1,37628,798 4.8%  
Depreciation Rs m264469,770 0.1%   
Interest Rs m063,415 0.0%   
Profit before tax Rs m1,352-483,372 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m170123,279 0.1%   
Tax Rs m583-6,126 -9.5%   
Profit after tax Rs m939-353,967 -0.3%  
Gross profit margin %12.52.6 475.7%  
Effective tax rate %43.11.3 3,401.7%   
Net profit margin %8.5-32.2 -26.4%  
BALANCE SHEET DATA
Current assets Rs m7,523450,725 1.7%   
Current liabilities Rs m2,253398,726 0.6%   
Net working cap to sales %47.74.7 1,009.0%  
Current ratio x3.31.1 295.5%  
Inventory Days Days5220 266.3%  
Debtors Days Days4166 61.2%  
Net fixed assets Rs m1,240124,393 1.0%   
Share capital Rs m1660-   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,3334,532,586 0.2%   
Long term debt Rs m01,596,088 0.0%   
Total assets Rs m9,9127,085,463 0.1%  
Interest coverage xNM-6.6-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.10.2 718.1%   
Return on assets %9.5-4.1 -231.0%  
Return on equity %12.8-7.8 -164.0%  
Return on capital %20.8-4.8 -428.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m537392,607 0.1%  
From Investments Rs m-476215,687 -0.2%  
From Financial Activity Rs m-220-673,832 0.0%  
Net Cashflow Rs m-160-65,211 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.61 Rs / USD

Compare MERCK With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare MERCK With: VENUS REMEDIES  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFESCIENCES  DR. DATSONS LABS  



Today's Market

US-China Trade Talks, Domestic Air Passenger Traffic, and Top Stocks in Focus Today(Pre-Open)

Indian share markets continued to witness volatility during closing hours yesterday and ended on a flat note. Gains were seen in the realty sector and consumer durables sector.

Related Views On News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


Jun 19, 2019 (Close)

TRACK MERCK

COMPARE MERCK WITH

MARKET STATS